For a Change of Heart, Would-Be Egg Donors Face Threats and Bills
By Alison Motluk,
UNDARK
| 02. 24. 2020
Some fertility clinics and agencies are taking a harsh approach to women who change their minds about donating eggs.
In the summer of 2017, Julie Johnson saw a Facebook ad about egg donation. Somebody out there — an older mother, maybe, or a gay couple — needed eggs to have a child, and hers could be removed and given to them. In return, she could make a few thousand dollars. After giving it some thought, Johnson decided egg donation was something she might like to try. She filled out online forms about her family’s health history and about herself. Not long after, someone from a network of clinics called the Fertility Institutes got in touch about an appointment.
The Fertility Institutes was founded in Los Angeles, but it has offices and affiliates across the country and around the world. During Johnson’s first meeting with the group, at an office in Draper, Utah, near her home, she went through a basic health screening and learned more about the process.
Egg donation isn’t easy. Typically, it requires a woman to synchronize her ovulation cycle with that of the recipient woman, using birth control pills. Then the donor injects herself with hormones...
Related Articles
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Peter Ward, Slate | 03.30.2026
I’m in a cramped examination room at a clinic in Panama City. The lights are dim, and calming classical music plays from built-in speakers. A nurse has injected a dose of stem cells into Kenneth Scott through an IV in...
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...